Beta Drugs Ltd Half Yearly Results

Gross Sales

182.05

180.3

154.45

141.27

114.72

Excise Duty

0

0

0

0

0

Net Sales

182.05

180.3

154.45

141.27

114.72

Other Operating Income

0

0

0

0

0

Other Income

4.93

1.51

0.82

0.54

0.43

Total Income

186.98

181.81

155.27

141.81

115.15

Total Expenditure

150.82

141.5

127.3

108.41

88.4

PBIDT

36.16

40.31

27.96

33.39

26.75

Interest

5.16

1.83

1.45

1.37

1.27

PBDT

31

38.49

26.51

32.02

25.47

Depreciation

6.8

5.71

4.34

5.44

5.58

Minority Interest Before NP

0

0

0

0

0

Tax

6.42

8.55

5.61

6.92

5.33

Deferred Tax

-0.21

-0.21

0

-0.21

-0.32

Reported Profit After Tax

17.98

24.44

16.56

19.87

14.88

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

17.98

24.44

16.56

19.87

14.88

Extra-ordinary Items

-3.36

0

0

0

0

Adjusted Profit After Extra-ordinary item

21.34

24.44

16.56

19.87

14.88

EPS (Unit Curr.)

17.81

25.42

17.23

20.67

15.48

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.09

9.61

9.61

9.61

9.61

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.86

22.35

18.1

23.63

23.31

PBDTM(%)

-

-

-

-

-

PATM(%)

9.87

13.55

10.72

14.06

12.97